Non-Invasive Chromosomal Evaluation of Trisomy Study
Status: | Recruiting |
---|---|
Conditions: | Other Indications, Other Indications |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - 60 |
Updated: | 4/21/2016 |
Start Date: | April 2014 |
End Date: | April 2016 |
Contact: | Romielle Aquino |
Email: | raquino@ariosadx.com |
Phone: | 408-209-9098 |
This study is being conducted to provide clinically annotated samples to support continued
improvements in the Ariosa Test content, methodology, specimen processing and quality
control.
improvements in the Ariosa Test content, methodology, specimen processing and quality
control.
Inclusion Criteria:
- 1. Subject is at least 18 years old and can provide informed consent;
- 2. Subject has a viable singleton or twin pregnancy;
- 3. Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the
study blood draw;
- 4. Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic
analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis
and is known to have a fetus with a chromosomal abnormality confirmed by genetic
analysis.
Exclusion Criteria:
- 1. Subject has known aneuploidy;
- 2. Subject is pregnant with more than two fetuses or has had sonographic evidence of
three or more gestational sacs at any time during pregnancy;
- 3. Subject has a fetal demise (including natural or elective reduction) identified
prior to consent;
- 4. Subject has history of malignancy treated with chemotherapy and/or major surgery,
or bone marrow transplant;
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials